Matthieu Germain, PhDHead of Chemistry at NanobiotixSpeaker
Profile
Matthieu holds a doctorate in biotechnology. He joined Nanobiotix in 2004. With over 20 years in nanomedicine, he has authored more than 15 publications and scientific communications and holds 20 patents. He has held multiple positions at Nanobiotix, including leading the Nanoprimer platform and serving as CEO of the Nanobiotix spin-off Curadigm.
Agenda Sessions
The Nanoprimer Platform: Unlocking Extrahepatic Delivery of RNA-based Therapeutics
, 9:35amView Session

